Improvement in neoantigen prediction via integration of RNA sequencing data for variant calling

This integrative approach holds great potential for improving the selection of neoantigens for personalized cancer immunotherapy, ultimately leading to enhanced treatment outcomes and improved survival rates for cancer patients.